These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20382531)

  • 1. The relationship between quality and cost during the perioperative breast cancer episode of care.
    Landercasper J; Tafra L
    Breast; 2010 Aug; 19(4):289-96. PubMed ID: 20382531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative quality metrics for one step breast cancer surgery: a patient-centered approach.
    Smith TJ; Landercasper J; Gundrum JD; De Maiffe BM; Andersen JJ; Johnson JM; Haller PJ
    J Surg Oncol; 2010 Jul; 102(1):34-8. PubMed ID: 20578075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpreting the economic literature in oncology.
    Grusenmeyer PA; Wong YN
    J Clin Oncol; 2007 Jan; 25(2):196-202. PubMed ID: 17210940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quest for quality and economic effectiveness throughout the continuum of breast care.
    La Fargue MM; Coleman C
    Breast; 2010 Aug; 19(4):251-2. PubMed ID: 20392641
    [No Abstract]   [Full Text] [Related]  

  • 5. [Guidelines and quality assurance in plastic breast surgery].
    Olbrisch RR
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():173-7. PubMed ID: 9574121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effective use of breast biopsy techniques in a Veterans health care system.
    Hatmaker AR; Donahue RM; Tarpley JL; Pearson AS
    Am J Surg; 2006 Nov; 192(5):e37-41. PubMed ID: 17071179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of advanced nursing care on quality of life and cost outcomes of women diagnosed with breast cancer.
    Ritz LJ; Nissen MJ; Swenson KK; Farrell JB; Sperduto PW; Sladek ML; Lally RM; Schroeder LM
    Oncol Nurs Forum; 2000 Jul; 27(6):923-32. PubMed ID: 10920832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of cancer economics. Based on a presentation by C. Daniel Mullins, PhD.
    Am J Manag Care; 1999 Jun; 5(6 Suppl):S371-6. PubMed ID: 10538848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The perioperative process: a system of providing quality, convenient, cost-effective surgical services.
    Talarico JF
    Health Care Superv; 1999 Mar; 17(3):44-50. PubMed ID: 10351045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of a quality improvement collaborative focusing on patients with diabetes.
    Schouten LM; Niessen LW; van de Pas JW; Grol RP; Hulscher ME
    Med Care; 2010 Oct; 48(10):884-91. PubMed ID: 20808258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-effectiveness of percutaneous core needle breast biopsy (CNBB) versus open surgical biopsy (OSB) of nonpalpable breast lesions: metaanalysis and cost evaluation for German-speaking countries].
    Gruber R; Bernt R; Helbich TH
    Rofo; 2008 Feb; 180(2):134-42. PubMed ID: 18058636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality measures for breast cancer surgery: initial validation of feasibility and assessment of variation among surgeons.
    McCahill LE; Privette A; James T; Sheehey-Jones J; Ratliff J; Majercik D; Krag DN; Stanley M; Harlow S
    Arch Surg; 2009 May; 144(5):455-62; discussion 462-3. PubMed ID: 19451489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-day surgery in a series of 150 breast cancer patients: efficacy and cost-benefit analysis.
    Ranieri E; Caprio G; Fobert MT; Civitelli L; Ceccarelli F; Barberi S; Virno F
    Chir Ital; 2004; 56(3):415-8. PubMed ID: 15287640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer in limited-resource countries: treatment and allocation of resources.
    Eniu A; Carlson RW; Aziz Z; Bines J; Hortobágyi GN; Bese NS; Love RR; Vikram B; Kurkure A; Anderson BO;
    Breast J; 2006; 12 Suppl 1():S38-53. PubMed ID: 16430398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the cost of delayed and immediate autologous breast reconstruction in Belgium.
    Neyt MJ; Blondeel PN; Morrison CM; Albrecht JA
    Br J Plast Surg; 2005 Jun; 58(4):493-7. PubMed ID: 15897033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definitive breast cancer surgery as an outpatient: a rational basis for the transition.
    Hoehn JL
    Semin Surg Oncol; 1996; 12(1):53-8. PubMed ID: 8821410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost benefit aspects of quality: is there a return on the investment?].
    Wasserfallen JB
    Rev Med Suisse Romande; 2001 Nov; 121(11):827-30. PubMed ID: 11765568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer--prevalence-based healthcare costs.
    Norlund A; Alvegård T; Lithman T; Merlo J; Noreen D
    Scand J Urol Nephrol; 2003; 37(5):371-5. PubMed ID: 14594683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of a short stay admission programme for breast cancer surgery.
    de Kok M; Dirksen CD; Kessels AG; van der Weijden T; van de Velde CJ; Roukema JA; Bell AV; van der Ent FW; von Meyenfeldt MF
    Acta Oncol; 2010 Apr; 49(3):338-46. PubMed ID: 20397768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.